Oral and sublingual peptides are an emerging category
Slimming jabs: 'I thought my body was shutting down' Published For those with severe weight issues, semaglutide the active ingredient in slimming drugs can be a life-changer
Weight loss typically triggers adaptive reductions in metabolic rate, which can slow further weight reduction and promote regain
CagriSema CagriSema is an investigational fixed-dose combination of cagrilintide, a long-acting amylin analog, and semaglutide, a GLP-1 receptor agonist, co-administered once weekly and studied in Phase 3 trials for obesity and type 2 diabetes.
Summary: Lipo C with retatrutide refers to the combined use of an unlicensed lipotropic injection and an investigational triple receptor agonist, neither of which holds a UK marketing authorisation, meaning this combination should not be used outside approved clinical trials
Limiting sun exposure after completion of skin lightening treatment is the best way to prevent dark spots and melasma from returning